Wildiers H, Armstrong A, Cuypere E, Dalenc F, et al. Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial. Clin Cancer Res 2023 Nov 8. doi: 10.1158/1078-0432.CCR-23-1173.
PMID: 37939105